Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
TissueTech said that it added another $15 million to its coffers, led by prior backers River Cities Capital Funds and Ballast Point Ventures.
Doral, Fla.-based TissueTech makes amniotic membrane- and umbilical cord-based products designed to treat ocular surface diseases (its Bio-Tissue subsidiary) and musculoskeletal conditions and wound care (its Amniox Medical business). Read more
GI Dynamics said in a regulatory filing that it fired chief medical officer Dr. David Maggs “for cause.”
The Lexington, Mass.-based medical device company did not otherwise elaborate on the reason for Maggs’s departure, which was effective June 18, according to the filing. Read more
Medtronic said that it is recalling certain lots of its Covidien Shiley tracheostomy tubes after receiving complaints and reports of serious injury. The company said it began notifying hospitals and distributors worldwide on May 8 of the issue.
The recalled tracheostomy tubes, manufactured after November 29, 2012, were formed with a wider-angle bend than standard models, the Fridley, Minn.-based medical giant said. Read more